Firms

Compound

United States · New York, New York · Palo Alto, California

compound.vc

signal.nfx.com

goldi.ai

Compound is an NYC based venture capital firm that invests in bleeding-edge technology being built by outliers.

Founded: 2008
Type: Venture capital

Funds4

Compound Explorer I, L.P.2026-08-102026-08-10—
Separate USD35M regulatory target, USD0sold as of filing; mandate/final close unknown.
Compound 2026, L.P.2026-03-112026-03-11—
USD115M regulatory offering target, USD0sold at filing. Later ADV aggregation USD116M gross assets is different metric, not verified final close or current zero capital.
Compound II2024-04-192024-04-19$73M
Official2023 annual letter published2024-04-19; started investing September2021. Publication distinct from investment vintage.
Compound I—$50M
USD 50 million, historical deployed fund; first officially named Compound fund, third fund of the management company. | Michael Dempsey, [Closing Out The Fund](https://mhdempsey.substack.com/p/closing-out-the-fund), 2021-07-28. He discusses closing its new-investment period after approximately five years.

Team

John Palmer Compound, Venture Partner - Crypto	$1M$400K – $1M	Brooklyn, New York
Josh Nussbaum Compound, Venture Partner	$1M$400K – $1M	Brooklyn, New York
Smac Compound, Partner	$1M$400K – $1M	New York, New York
Dan Zigmond Compound, Venture Partner - Data Science & AI	$1M$400K – $1M	Palo Alto, California · Menlo Park, California
Michael Dempsey Compound, Managing Partner	$1M$400K – $1M	United States
Shelby Newsad Compound, Partner	$1M$400K – $1M	United States
Ben Krall Compound, Venture Partner	$1M— – —
Celeste Holz-Schietinger Compound, Venture Partner - Biology	—— – —
David Hirsch Compound, General Partner	—— – —
Drew Gray Compound, Venture Partner - AI & Robotics	—— – —
Jason Kelly Compound, Venture Partner - Biology & Healthcare	—— – —
Mackenzie Morehead Compound, Researcher	—— – —
Ron Boger Compound, Venture Partner - Computational Biology	—— – —
Tara Eckert Compound, CFO	—— – —

Investments

$—Unknown date	Boost Biomes	Compound
$—2026-10-06	Minerva Humanoids	General Catalyst, Long Journey Ventures, Credo Ventures, RunwayVC, MVP Ventures, Kaya VC, Compound, Walter Ventures
$13M2026	SyntheticFi	Compound, Y Combinator, Social Leverage
$50M2026	Orbital Inc.	Compound, Station F, Plural Platform, Radical Ventures, NVentures, Fly Ventures, Plural
$8M2025-12-08	The General Intelligence Company	Compound, The House Fund, Union Square Ventures, Acrew Capital, Agent Capital
$—2025-03-28	Alljoined	Khosla Ventures, Conviction, Compound, ARTIS, Xtal Ventures, Topology, First Spark Ventures, Valor, Constellation, Jeff Dean, Mina Fahmi, Casey Caruso, Anastasis Germanidis, Guillermo Rauch, Oliver Cameron, Vas Bailey
$4M2025	Pear Protocol	Compound, Castle Island Ventures
$17M2024-09-10	aifleet	Compound, Obvious Ventures, Volvo Group Venture Capital, Ibex Investors
$5M2024-04-23	Prime Intellect	Compound, Protocol Labs, Distributed Ventures, Collab+Currency, CoinFund
$16M2024	aifleet	Compound, Obvious Ventures, Volvo Group Venture Capital, Ibex Investors, Heron Rock
$1M2024	Briefly Bio	Compound, NP-Hard Ventures
$—2023-05-15	Pear Bio	Compound, SOSV, Octopus Ventures, Hoxton Ventures, Fly Ventures, Crista Galli Ventures
$—2023	Pear Protocol	Compound
$43M2022-11-28	Bionaut Labs	Khosla Ventures, Vinod Khosla, Dolby Family Ventures, Sixty Degree Capital, What If Ventures, OurCrowd, Gaingels, Upfront Ventures, Compound
$41M2022-11-08	Juvena Therapeutics	Mubadala Capital, Horizons Ventures, Manta Ray, IRONGREY, Alumni Ventures, Plum Alley, Jeff Dean, BoxOne Ventures, Compound, Felicis, Bison Ventures
$9M2022-10-27	Onward	Founders Fund, Gaingels, Compound, Citi Ventures, GingerBread Capital, TTV Capital, Correlation Ventures
$41M2022-01-19	Nowsta	Compound, Real Ventures, Redpoint Ventures, Tribe Capital, Green Visor Capital, VMG Catalyst
$200M2022-01-18	Wayve	Eclipse, Compound, D1 Capital Partners, M12, Lince Capital, Baillie Gifford, Moore Strategic Ventures, Balderton Capital
$2M2021-06-22	Donut	Compound, Redalpine, NVentures
$—2021-03-25	Ease (company)	Compound, Propel Venture Partners, Freestyle Capital, Upside Partnership, Spectrum Equity, Centana Growth Partners
$20M2021-03-03	Bionaut Labs	Samir Kaul, Compound
$24M2020-05-28	Tia	Compound, Kleiner Perkins, ACME Capital, Threshold Ventures
$50M2019-05-29	Talkspace	Compound, Soma Capital, Revolution Growth, Spark Capital, Norwest Venture Partners, Qumra Capital, Jeff Crowe
$4M2019-05-28	Betterview	Compound, Winklevoss Capital Management, ManchesterStory Group, Nationwide, Guidewire Software
$4M2019-05-28	BetterView	Compound, 500 Global, ManchesterStory Group, Nationwide
$8M2018-05-16	Compound	Bain Capital, Abstract Ventures, Polychain Capital, Compound, DHVC (Danhua Capital), Bain Capital Ventures, Transmedia Capital
$36M2018-04-20	Orchid Labs	Compound, DFJ Growth, BoxGroup, Sequoia Capital, Sequoia, Blockchain Capital
$3M2017-10-05	Onward	Founders Fund, Gaingels, Compound
$31M2017-09-07	Talkspace	Compound, SoftBank Vision Fund, Spark Capital, Norwest Venture Partners, Qumra Capital
$6M2017-06-20	EaseCentral	Compound, Propel Venture Partners, Freestyle Capital, Transmedia Capital, Upside Partnership
$4M2017-01-05	Stacks	Compound, Union Square Ventures, Lux Capital, Version One Ventures, Digital Currency Group
$4M2017	Blockstack	Compound, Foundation Capital, Union Square Ventures, OpenOcean, Lux Capital, Version One Ventures
$2M2017	BetterView	Compound, 500 Global, Haystack, Winklevoss Capital Management, 645 Ventures, MetaProp
$15M2016-06-14	Talkspace	Compound, Spark Capital, Norwest Venture Partners, Jeff Crowe
$2M2015-12-18	Payjoy	Compound, Red Swan Ventures
$6M2015-09-01	LotusFlare	Compound, GV
$9M2015-05-12	Talkspace	Compound, SoftBank Vision Fund, Spark Capital
$4M2015-04-09	Stanza	Compound, Western Technology Investment, Founder Collective, Tectonic Ventures
$5M2014-12-16	Boxbee, Inc.	Compound, Floodgate Fund, Northgate Capital
$2M2014-12-09	UpCounsel	Compound, Crosslink Capital, Homebrew
$5M2014-11-06	Wanderu Inc.	Compound, 500 Global, Alta Partners
$1M2014-07-29	Voyat	Compound, ENIAC Ventures, BoxGroup
$1M2014-05-28	Bindo	Compound, Hearst Ventures
$11M2013-05-08	Movable Ink	Compound, WS Investment Company, Silicon Valley Bank, Intel Capital, ff Venture Capital, Contour Venture Partners
$12M2012-11-21	Chango	Compound, Inovia Capital, Rho Capital Partners, John Elton, Geoff Judge
$1M2012-03-26	AppBoy	Compound, Blumberg Capital, Bullpen Capital, Accelerator Ventures
$2M2012-01-31	Artspace	Compound, The Blue Venture Fund, Felicis, Accelerator Ventures
$1M2011-11-23	AppBoy	Compound, Blumberg Capital, Bullpen Capital, Accelerator Ventures
$1MUnknown date	Briefly	Compound, NP-Hard Ventures
$1MUnknown date	Vitae Industries	Compound, Techstars, BoxGroup, Founder Collective, Lerer Hippeau
$7MUnknown date	Viyet	Compound, Female Founders Fund, Rosecliff, RiverPark Ventures, Social Starts
$8MUnknown date	General Intelligence	Compound, The House Fund, Union Square Ventures, Acrew Capital, Agent Capital
$15MUnknown date	Satomic	Compound, Riot Ventures, HOF Capital
$2MUnknown date	Imvitro	Compound, LDV Capital, Fly Ventures, MMC Ventures
$7MUnknown date	Luda	Compound, BITKRAFT Ventures
$—Unknown date	Soot	Compound, Village Global, Upfront Ventures
$15MUnknown date	The Clearing Company	Compound, Union Square Ventures, Coinbase Ventures, Variant, Earl Grey Capital, Cursor Capital
$13MUnknown date	Valius Sciences	Compound, 8VC, Basis Set Ventures
$15MUnknown date	VRGL	Compound, Fin Capital, Northwestern Mutual Future Ventures, MissionOG, Flyover Capital, FINTOP Capital
$33MUnknown date	Achira	Compound, Dimension, Amplify Partners, NVIDIA Corporation
$5MUnknown date	SuppCo	Compound, Union Square Ventures, Friends & Family Capital, True Ventures, BoxGroup
$14MUnknown date	Digitalgenius	Compound, Runa Capital, Salesforce Ventures, Global Founders Capital, RRE Ventures, MMC Ventures
$2MUnknown date	Snowball	Compound, GV, First Round Capital, Golden Ventures, Nexus Venture Partners, Felicis
$2MUnknown date	Insensi	Compound, SV Angel, Felicis, SparkLabs, Prudence Holdings
$3MUnknown date	Onward	Compound, Gaingels, Founders Fund
$—Unknown date	Casa	Compound, Precursor Ventures, Boost VC, Lerer Hippeau
$—Unknown date	Violet	Compound
$—Unknown date	Plural	Compound
$—Unknown date	Pear	Compound
$—Unknown date	Orchid	Compound
$—Unknown date	Kadena	Compound
$—Unknown date	ISO	Compound
$—Unknown date	Helium	Compound
$—Unknown date	Hedgey Finance	Compound
$—Unknown date	Defined	Compound
$—Unknown date	Casa	Compound
$—Unknown date	Bio Protocol	Compound
$—Unknown date	Alliance DAO	Compound
$—Unknown date	Agoric	Compound
$—Unknown date	Payjoy	Compound
$—Unknown date	Panthalassa	Compound
$—Unknown date	Nowsta	Compound
$—Unknown date	Noat	Compound
$—Unknown date	Magrathea Metals	Compound
$—Unknown date	Ease	Compound
$—Unknown date	Daily	Compound
$—Unknown date	Catalyst	Compound
$—Unknown date	Antimatter	Compound
$—Unknown date	Threshold	Compound
$—Unknown date	The Graph	Compound
$—Unknown date	The Clearing Company	Compound
$—Unknown date	Stacks	Compound
$—Unknown date	Plural Energy	Compound
$—Unknown date	PartyDAO	Compound
$—Unknown date	Molecule	Compound
$—Unknown date	Manifest	Compound
$—Unknown date	Livepeer	Compound
$—Unknown date	Kinetiq	Compound
$—Unknown date	HairDAO	Compound
$—Unknown date	Delpho	Compound
$—Unknown date	Dapper Labs	Compound
$—Unknown date	Compound	Compound
$—Unknown date	Arbitrum	Compound
$—Unknown date	Vitae	Compound
$—Unknown date	Valius	Compound
$—Unknown date	Tia	Compound
$—Unknown date	Talkspace	Compound
$—Unknown date	SuppCo	Compound
$—Unknown date	Spaero	Compound
$—Unknown date	Red Queen Bio	Compound
$—Unknown date	Polyphron	Compound
$—Unknown date	Pheiron	Compound
$—Unknown date	Pear Bio	Compound
$—Unknown date	Los Angeles Project	Compound
$—Unknown date	Juvena Therapeutics	Compound
$—Unknown date	Imvitro	Compound
$—Unknown date	Culture Biosciences	Compound
$—Unknown date	Conception	Compound
$—Unknown date	Cellvoyant	Compound
$—Unknown date	Briefly Bio	Compound
$—Unknown date	Bionaut Labs	Compound, re.Mind Capital
$—Unknown date	Atlas	Compound
$—Unknown date	Achira	Compound
$—Unknown date	Wayve	Compound
$—Unknown date	The General Intelligence Company	Compound
$—Unknown date	SparkAI	Compound
$—Unknown date	Soot	Compound
$—Unknown date	Shadows	Compound
$—Unknown date	Runway	Compound
$—Unknown date	Prime Intellect	Compound
$—Unknown date	Osaro	Compound
$—Unknown date	Orbital Materials	Compound
$—Unknown date	Luda	Compound
$—Unknown date	Hyphen	Compound
$—Unknown date	FORT Robotics	Compound
$—Unknown date	Deepgram	Compound
$—Unknown date	CrowdAI	Compound
$—Unknown date	Alectio	Compound
$—Unknown date	AIFleet	Compound
$2M2015-05-22	Switch (job discovery)	Compound, Group 11, BAM Ventures, Rhodium
$—Unknown date	Sarcophagus	Compound
$—Unknown date	Parcel	Compound
$—Unknown date	Engi	Compound

team@apexlogos.ai2 days ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund size and status | Vehicle | Amount and interpretation | Dated supporting evidence | | --- | --- | --- | | Compound I | USD 50 million, historical deployed fund; first officially named Compound fund, third fund of the management company. | Michael Dempsey, [Closing Out The Fund](https://mhdempsey.substack.com/p/closing-out-the-fund), 2021-07-28. He discusses closing its new-investment period after approximately five years. | | Compound II | **USD 73 million**, actual fund described by the firm; started investing September 2021. | Official [2023 annual letter](https://www.compound.vc/writing/compound-annual-letter-2023), published 2024-04-19. This is the latest directly verified operating-fund size in a firm announcement found here. | | Compound 2026, L.P. | **USD 115 million offering target**, not a verified final close. March filing reports USD 0 sold, zero investors and first sale yet to occur. | [SEC Form D](https://www.sec.gov/Archives/edgar/data/2114614/000110465926026411/xslFormDX01/primary_doc.xml), signed/filed 2026-03-11; identifies Dempsey and Hirsch and the same New York address. | | Compound Explorer I, L.P. | **USD 35 million offering target**, USD 0 sold and first sale yet to occur at filing. Treat as a separate vehicle; mandate and eventual close not established. | [SEC Form D](https://www.sec.gov/Archives/edgar/data/2147721/000110465926093414/xslFormDX01/primary_doc.xml), signed/filed 2026-08-10; identifies Dempsey and Hirsch. | A [FormDs aggregation for Compound 2026](https://formds.com/issuers/compound-2026-l-p), accessed 2026-10-06, associates a June 4, 2026 Form ADV with USD 116 million gross assets and 58 beneficial owners. That is a later, different measurement from offering sales, and suggests subsequent activity; the original historical ADV was not independently retrieved in this review. Do not claim zero capital as of October or a USD 115/116 million final close on that basis. The [official adviser profile](https://adviserinfo.sec.gov/firm/summary/165300) rendered only a shell in the browser. Aggregate AUM and currently deployable capital remain unverified. There is a historical inconsistency: a [2024 interview with Dempsey](https://www.buzzsprout.com/2390643/episodes/15709780-001-how-mike-dempsey-finds-100x-moic-investments-for-compound-featuring-kesar-varma-from-upfront-ventures), September 2024 episode, describes the 2016 first fund as USD 40 million and Fund II initially closing on USD 60 million before additional capital brought it to USD 73 million. Preserve the USD 40/50 million Fund I conflict; do not silently harmonize it or sum these amounts as AUM. Signal check sizes are neither fund size nor firm investment budget. Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | Compound I | USD 50000000 | Unknown | | Compound II | USD 73000000 | 2024-04-19 | | Compound 2026, L.P. | Undisclosed / unverified | 2026-03-11 | | Compound Explorer I, L.P. | Undisclosed / unverified | 2026-08-10 |
team@apexlogos.ai2 days ago
Match research 2026-10-06 / Compound / sha256:c128d8cbf0600b603a53daf4a91807f272fc047348981a86a7cd89367518caf3 / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. The [official Compound portfolio](https://www.compound.vc/portfolio), undated, accessed 2026-10-06, corroborates all five and additionally lists Osaro, FORT Robotics, Hyphen, Conception, Cellvoyant, Juvena Therapeutics, Pear Bio, Magrathea Metals and Panthalassa. These are additional investment leads, not verified financing details. Osaro is listed under robotics/AI; no reliable primary round attribution was located here. The catalogue alone does not prove a present holding, entry stage, check, ownership or exit status. ## Previous neurotech investments and boundaries **Alljoined — verified direct neurotechnology.** The company's [own launch post on LinkedIn](https://www.linkedin.com/posts/alljoined_introducing-alljoined-uncovering-thoughts-activity-7311409825496633345-S3N9), directly read 2026-10-06, names Compound among investors alongside Khosla, Conviction, ARTIS, Xtal, Topology and First Spark. It describes non-invasive EEG decoding and image reconstruction. The public rendering displays only a relative age; the saved Adex snapshot attributes its linked [X launch announcement](https://x.com/alljoined/status/1905639044958359595) to **2025-03-28**. Retain that date as a baseline date requiring exact-post verification; do not present it as a freshly confirmed financing date. No investment amount, exact legal vehicle, closing date or stage was disclosed in the readable primary announcement. The [official Alljoined website](https://www.alljoined.com/), undated, accessed 2026-10-06, discusses EEG-to-image decoding, its 2025 million-trial dataset and a 2026 multi-subject model. That confirms neural technology; research demonstrations do not establish a commercially ready mind-reading product. **Bionaut Labs — CNS therapeutic device/microrobotics, separate from BCI.** Its official release describes delivery to difficult-to-access brain regions and programmes for glioma and Dandy-Walker syndrome. Compound's 2021 launch-financing and 2022 Series B participation are explicit. It is relevant to neurotechnology in a broad neurological-device sense, but should be tagged separately from neural recording, stimulation or interfaces. Later extension financing is mentioned in [BioscienceLA's reproduction of Fortune reporting](https://www.biosciencela.org/recent-events-news/exclusive-bionaut-labs-raises-an-extension-round-in-preparation-for-micro-robot-clinical-trials), accessed 2026-10-06; it names other existing investors without establishing Compound's participation in that extension. Do not infer follow-on participation from historical portfolio status. **Adjacent or excluded:** Talkspace is present in the official portfolio and Adex, but mental-health counselling alone is not direct neurotech. The saved record's 2017 Onward “screen addictions” app and 2022 Onward co-parent finance app need identity separation and neither supports neural hardware. Switch Therapeutics is not supported by the snapshot's 2015 “Tinder for jobs” funding article. General AI companies are not counted as neurotech solely because their models are called neural networks. ## Conflicts, gaps and concrete later-review notes 1. **Severe Compound name collision:** The snapshot assigns a **2019-11-15 USD 25 million Series A** from a Compound Finance article as a round raised by this investment firm and repeats multiple Compound-company participations. The official crypto portfolio itself lists a separate investee named Compound. Review the DeFi company's legal/entity ID and reattach those company rounds; never use them for VC fundraising. 2. **Switch entity mismatch:** Snapshot `Switch Therapeutics` links to a 2015 job-matching startup article. Quarantine this attribution until the appropriate company identity is checked; it provides no verified biotech/neurotech investment here. 3. Review apparent duplicate names (AIFleet/aifleet; BetterView/Betterview; The General Intelligence Company/General Intelligence; Briefly/Briefly Bio). `Orbital`/`Orbital Inc.` may represent Orbital Materials' rebranding but require entity-specific confirmation before merging. 4. Add verified Alljoined and Bionaut evidence with distinct direct-BCI versus CNS-device classifications. Preserve missing financing stage/amount for Alljoined and date precision caveat. Preserve Bionaut's exact USD 43.2 million instead of rounding to USD 43 million. 5. Update fund records as individual vehicles: USD 73 million Compound II and separate 2026 offering targets. Verify historical ADV and new amended Form Ds before claiming a current final close or total AUM. Preserve historical Fund I USD 40/50 million conflict. 6. Confirm current team roles against official biographies; duplicate and imported roles in Adex are not a current headcount. Signal's person transactions should not automatically become firm-level investments. 7. Specific allocation, legal investor vehicle, ownership and full portfolio history remain undisclosed. No exhaustive claim about the absence of further neurotech investments is warranted. All sources above were accessed **2026-10-06**. Publication/signature dates are stated where established; undated firm pages and Signal are expressly marked. Findings are source-based research with uncertainty retained, ready for a later authorized Adex review.
team@apexlogos.ai2 days ago
Match research 2026-10-06 / Compound / sha256:c128d8cbf0600b603a53daf4a91807f272fc047348981a86a7cd89367518caf3 / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # Compound - **Exact Adex ID:** `Compound` - **Adex webpage:** https://adex.page/firms/Compound - **Official website:** https://www.compound.vc/ - **Research date:** 2026-10-06 - **Status:** Complete research for later review; no Adex or database changes made. Compound is a New York research-driven venture firm with verified scientific and technical investments, including direct neurotechnology investment Alljoined and CNS microrobotics developer Bionaut Labs. Its confirmed disclosed Fund II size is USD 73 million; newer 2026 vehicles have regulatory offering targets requiring separate treatment from closed capital. The firm is distinct from its similarly named DeFi portfolio company. ## Starting evidence and identity The saved read-only MCP snapshot `data/research/_sources/Compound.adex.json` (retrieved 2026-10-06) identifies Compound as founded in 2008, describes an NYC venture firm, lists Michael Dempsey, Smac, Shelby Newsad and numerous venture partners, and provides portfolio/round leads. Its investor profile check fields are null. The record contains duplicate roles, duplicate investments and identity collisions described below. Existing Adex and Goldilocks-derived claims were treated as leads rather than independently verified facts. [NFX Signal firm page](https://signal.nfx.com/firms/compound), undated, directly read 2026-10-06, gives founding year 2008 and locations New York and Palo Alto. The accessible rendering contained a team heading without the team list; the saved record's six-person count is therefore not independently established. [Michael Dempsey's Signal profile](https://signal.nfx.com/investors/michael-dempsey), directly read the same date, lists USD 400,000–1.5 million investment range, USD 1 million sweet spot, a USD 50 million “current” fund and pre-seed/seed/Series A sector rankings. It also lists historical Bionaut transactions. These are undated person-profile claims; the USD 50 million current-fund label is stale relative to Fund II and should not populate current firm fund size. Its transaction and employment lists are not exhaustive or uniformly reliable. The [official firm about page](https://www.compound.vc/about), undated, accessed 2026-10-06, confirms Michael Dempsey as managing partner, David Hirsch as general partner, Smac and Shelby Newsad as partners and Tara Eckert as CFO. The official homepage gives the New York office at 414 Broadway. Founding year is supported by Signal and the baseline, rather than a newly located official founding announcement. ## Fund size and status | Vehicle | Amount and interpretation | Dated supporting evidence | | --- | --- | --- | | Compound I | USD 50 million, historical deployed fund; first officially named Compound fund, third fund of the management company. | Michael Dempsey, [Closing Out The Fund](https://mhdempsey.substack.com/p/closing-out-the-fund), 2021-07-28. He discusses closing its new-investment period after approximately five years. | | Compound II | **USD 73 million**, actual fund described by the firm; started investing September 2021. | Official [2023 annual letter](https://www.compound.vc/writing/compound-annual-letter-2023), published 2024-04-19. This is the latest directly verified operating-fund size in a firm announcement found here. | | Compound 2026, L.P. | **USD 115 million offering target**, not a verified final close. March filing reports USD 0 sold, zero investors and first sale yet to occur. | [SEC Form D](https://www.sec.gov/Archives/edgar/data/2114614/000110465926026411/xslFormDX01/primary_doc.xml), signed/filed 2026-03-11; identifies Dempsey and Hirsch and the same New York address. | | Compound Explorer I, L.P. | **USD 35 million offering target**, USD 0 sold and first sale yet to occur at filing. Treat as a separate vehicle; mandate and eventual close not established. | [SEC Form D](https://www.sec.gov/Archives/edgar/data/2147721/000110465926093414/xslFormDX01/primary_doc.xml), signed/filed 2026-08-10; identifies Dempsey and Hirsch. | A [FormDs aggregation for Compound 2026](https://formds.com/issuers/compound-2026-l-p), accessed 2026-10-06, associates a June 4, 2026 Form ADV with USD 116 million gross assets and 58 beneficial owners. That is a later, different measurement from offering sales, and suggests subsequent activity; the original historical ADV was not independently retrieved in this review. Do not claim zero capital as of October or a USD 115/116 million final close on that basis. The [official adviser profile](https://adviserinfo.sec.gov/firm/summary/165300) rendered only a shell in the browser. Aggregate AUM and currently deployable capital remain unverified. There is a historical inconsistency: a [2024 interview with Dempsey](https://www.buzzsprout.com/2390643/episodes/15709780-001-how-mike-dempsey-finds-100x-moic-investments-for-compound-featuring-kesar-varma-from-upfront-ventures), September 2024 episode, describes the 2016 first fund as USD 40 million and Fund II initially closing on USD 60 million before additional capital brought it to USD 73 million. Preserve the USD 40/50 million Fund I conflict; do not silently harmonize it or sum these amounts as AUM. Signal check sizes are neither fund size nor firm investment budget. ## Investment stages The [official Compound Crypto about page](https://crypto.compound.vc/about), undated, accessed 2026-10-06, describes the firm as investing at the early stage across technical/scientific areas. The firm's [2024 deep-tech investor recruitment post](https://compoundvc.medium.com/compound-is-hiring-a-deep-tech-investor-in-2024-a84c0e3c2be4) requests a pre-Series B company thesis. Combined with Signal's rankings, pre-seed, seed and Series A are supported early-stage orientations, with rankings being weaker evidence than a formal mandate. Official Wayve and Bionaut funding releases establish Series B participation as historical follow-on behavior, not a general growth-stage mandate. No universal current check policy, ownership target or Explorer I stage mandate was verified. ## Previous deep-tech investments All listed amounts are entire company rounds, not Compound's individual check. Firm attribution is explicit where indicated; partner investments from prior employers are not credited to Compound. | Company | Technical rationale and firm attribution | Round/date and source | | --- | --- | --- | | **Wayve** | Embodied AI and autonomous driving; company names Compound as an early investor participating alongside other investors. | USD 200 million Series B led by Eclipse, announced **2022-01-18**. [Official Wayve announcement](https://wayve.ai/press/wayve-announces-200-million-in-funding-to-accelerate-the-development-of-av2-0-the-next-wave-of-autonomous-vehicles/). | | **Bionaut Labs** | Remote-controlled microscale medical robots for localized CNS treatment; scientific drug-delivery hardware rather than ordinary health software. Company explicitly names Compound among existing investors participating. | USD **43.2 million Series B**, **2022-11-28**, led by Khosla. [Company release](https://bionaut.squarespace.com/press-release/bionaut-labs-closes-43m-in-series-b-led-by-khosla-ventures-to-advance-first-in-class-micro-robotic-technology-and-remove-barriers-to-treat-rare-and-debilitating-diseases); primary release search-index accessible, direct open failed on retry. [Company newsroom](https://bionaut.squarespace.com/newsroom) also names Compound in USD 20 million launch financing on **2021-03-03**, without a definitive stage label in the visible release summary. | | **Alljoined** | EEG neural decoding and scientific machine-learning research; investment attribution and details below. | Named company-backed investor announcement and official Compound portfolio, with amount/stage unverified. | | **Culture Biosciences** | Physical bioreactors and automated bioprocess development; Compound explicitly calls it a portfolio company in its [High Tech CROs thesis](https://businessmodels.compound.vc/model/high-tech-cros). [Company products](https://www.culturebiosciences.com/) confirm hardware/laboratory infrastructure. | Sources undated, accessed **2026-10-06**. Specific Compound round/date not independently established; do not inherit the inconsistent third-party 2018/2019 seed or USD 6 million round claims. | | **Orbital Materials / Orbital Industries** | AI materials discovery; firm portfolio identifies Orbital Materials. | [Fortune](https://fortune.com/2026/05/28/exclusive-orbital-industries-raises-50-million-series-b-funding-round-ai-to-discover-exotic-new-materials/), **2026-05-28**: Compound participated in USD 50 million Series B. |
team@apexlogos.ai29 days ago
MATCH

Funds4

Team

Co-investing

Investments